{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"e36033996a1e","filters":{"venue":"Revisiones en Cáncer"}},"results":[{"id":"W4384076785","doi":"10.20960/revcancer.00025","title":"Beyond the first line of HER2+ metastatic breast cancer","year":2023,"lang":"es","type":"article","venue":"Revisiones en Cáncer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Metastatic breast cancer; Breast cancer; Oncology; Medicine; Internal medicine; Cancer","authors":[{"name":"Carmen Salvador Coloma","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.052102977007611,"gpt":0.4177754671121942,"spread":0.3656724901045831,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002057927,0.0003971858,0.0006309881,0.0009025219,0.0004488683,0.00194596,0.0006855492,0.001488449,0.008320632],"category_scores_gemma":[0.003656294,0.0001478392,0.0006784045,0.0004225097,0.001240621,0.001964056,0.001475206,0.003415977,0.002059515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002442908,"about_ca_system_score_gemma":0.002476066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001933557,"about_ca_topic_score_gemma":0.004788059,"domain_scores_codex":[0.9991407,0.0003037679,0.00006779853,0.000127461,0.0002118164,0.0001484367],"domain_scores_gemma":[0.9980902,0.0006674394,0.000243371,0.0001811772,0.0004970814,0.0003207187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004539335,0.000190703,0.002621108,0.00243226,0.00009802257,0.001721641,0.0004570319,0.0008356264,0.005703596,0.1167129,0.1788382,0.6899349],"study_design_scores_gemma":[0.00005579075,0.0003142077,0.00295938,0.001679349,0.00006087593,0.003867463,0.0001827336,0.0003849677,0.001703489,0.02743698,0.9613202,0.00003447427],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01908603,0.6023055,0.008273096,0.2035232,0.02281928,0.00007426032,0.0005096811,0.0003762865,0.1430327],"genre_scores_gemma":[0.2748795,0.502694,0.008159949,0.09328253,0.03609868,0.0001267622,0.0006413108,0.0002066818,0.08391064],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008320632,"threshold_uncertainty_score":0.02783525,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}